Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
EVGN vs AQB: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
AQB Captures Overall Composite Edge (44.6 HOLD vs 44.1 HOLD), While EVGN Leads 3–1 on Growth & Valuation Pillars
AQB Overall Winner
6-Pillar Tally: EVGN 3 – 1 AQB (2 Tie)
Matrix Metrics: EVGN 1 – 5 AQB
As of Nov 17, 2026, AquaBounty Technologies, Inc. (AQB) captures the overall head-to-head institutional edge over Evogene Ltd. (EVGN) on higher Unified Composite conviction (44.6/100 HOLD vs. 44.1/100 HOLD) after splitting the core matrix 5–1 (led by Profitability & Quality), while EVGN wins 3–1 across the 6-pillar growth and valuation breakdown. EVGN trades at $0.34 (N/M Forward P/E, -858.2% operating margin) versus AQB at $0.82 (N/M Forward P/E, 0.0% operating margin).
- Growth vs. Quality Trade-Off: AQB earns the overall head-to-head edge with a stronger Unified Composite Score (44.6/100 HOLD vs. EVGN 44.1/100 HOLD) and 0.93β · 117% Vol risk profile, whereas EVGN leads top-line expansion (-60.7% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: EVGN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.4); meanwhile AQB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About EVGN vs AQB
EVGN
Evogene Ltd.
$0.34
-13.17% 1D
Market Cap
$6.0M
TTM Revenue
$1.7M
Forward P/E
N/M
Beta / 30D Vol
1.37β · 138% Vol
Unified Composite Score
44.1
HOLD
Tech 42.0
Fund 44.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Neutral · Hold
AQB
Head-to-Head Winner
AquaBounty Technologies, Inc.
$0.82
+2.01% 1D
Market Cap
$9.7M
TTM Revenue
N/A
Forward P/E
N/M
Beta / 30D Vol
0.93β · 117% Vol
Unified Composite Score
44.6
HOLD
Tech 33.0
Fund 49.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (EVGN 3 – 1 AQB)
1. Valuation Multiples
Tie
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
N/M
N/M
2. Growth & Scale
EVGN
Revenue Growth (YoY)
-60.7%
-93.5%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$1.7M
N/A
Market Cap
$6.0M
$9.7M
3. Profitability & Quality
AQB
Gross Margin
-67.6%
N/A
Operating Margin
-858.2%
0.0%
Net Profit Margin
0.0%
0.0%
Return on Equity (ROE)
-182.8%
-68.9%
4. Balance Sheet & Cash Flow
EVGN
Cash Generation (TTM)
-$11M
-$7.2M
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
$6.5M Net Cash
$0.19 Book/Sh · -68.9% ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
EVGN
Options Structure Phase
UNCLASSIFIED
BREAKDOWN
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Neutral
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Biotechnology Operator
Farm Products Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: EVGN (1) vs AQB (5)| Institutional Metric | EVGN | AQB | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $6.0M | $9.7M | Tie | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | -60.7% | -93.5% | EVGN | |
| Operating Margin (TTM) | -858.2% | 0.0% | AQB | |
| Net Profit Margin | 0.0% | 0.0% | Tie | |
| Return on Equity (ROE) | -182.8% | -68.9% | AQB | |
| 52-Week Range Position | 9% ($0–$1) | 11% ($1–$2) | AQB | |
| Beta / 30D Volatility | 1.37β · 138% Vol | 0.93β · 117% Vol | AQB | |
| Unified Institutional Score | 44.1 / 100 (HOLD) | 44.6 / 100 (HOLD) | AQB | |
| Trailing 12M Revenue (USD) | $1.7M | N/A | Scale | |
| Gross Profit Margin (TTM) | -67.6% | N/A | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · N/M EV/Rev | N/M PEG · N/M EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$11M ($6.5M Net Cash) | -$7.2M ($0.19 Book/Sh · -68.9% ROE) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
EVGN +13.79 pp
3M Horizon
AQB +4.89 pp
6M Horizon
AQB +32.92 pp
1Y Horizon
AQB +48.32 pp
Financial Trajectory Multi-Year Revenue & Operating Margin Trajectory (USD)
| Period | EVGN Revenue | AQB Revenue | EVGN Op. Margin | AQB Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2021 | N/A | $0M | N/A | -1883.0% | AQB |
| FY2022 | N/A | $0M | N/A | -711.6% | AQB |
| FY2023 | N/A | $0M | N/A | -552.9% | AQB |
| Q1 '25 | $10M | N/A | -129.2% | N/A | EVGN |
| Q1 '26 | $0M | N/A | -943.1% | N/A | EVGN |
| Q2 '25 | $0M | N/A | -347.4% | N/A | EVGN |
| Q3 '25 | $0M | N/A | -873.1% | N/A | EVGN |
| Q4 '25 | $0M | N/A | -1659.9% | N/A | EVGN |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
EVGN
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact EVGN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
AQB
BREAKDOWN
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact AQB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
EVGN Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
AQB Moat Profile
Cyclical / Execution-Driven Positioning
Farm Products Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ EVGN vs AQB Key Questions & Quantitative Answers
As of Nov 17, 2026, AquaBounty Technologies, Inc. (AQB) captures the overall head-to-head institutional edge over Evogene Ltd. (EVGN) on higher Unified Composite conviction (44.6/100 HOLD vs. 44.1/100 HOLD) after splitting the core matrix 5–1 (led by Profitability & Quality), while EVGN wins 3–1 across the 6-pillar growth and valuation breakdown. EVGN trades at $0.34 (N/M Forward P/E, -858.2% operating margin) versus AQB at $0.82 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: AQB earns the overall head-to-head edge with a stronger Unified Composite Score (44.6/100 HOLD vs. EVGN 44.1/100 HOLD) and 0.93β · 117% Vol risk profile, whereas EVGN leads top-line expansion (-60.7% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: EVGN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.4); meanwhile AQB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
EVGN leads the Growth & Scale pillar: EVGN posts -60.7% YoY revenue growth and +0.0% YoY earnings growth on $1.7M TTM revenue (-67.6% gross margin, -858.2% operating margin), compared with AQB at -93.5% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). Across the 8-period historical trajectory (FY2021 to Q4 '25), EVGN cumulative revenue shifted N/A while AQB shifted N/A. In operating R&D and SG&A reinvestment, EVGN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AQB.
EVGN and AQB trade at balanced relative valuation multiples. EVGN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas AQB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EVGN (-182.8% ROE) versus AQB (-68.9% ROE) capital efficiency.
In options market volatility and institutional positioning, EVGN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.37β · 138% Vol realized risk). By comparison, AQB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.93β · 117% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
AQB vs EVGN · Reverse Pair
EVGN vs KMDA
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking
VRT vs ETN
· AI Power & Thermal